3xP Global has recently invested in Amparo Prosthetics, a pioneering medtech company transforming how prosthetic care is delivered. Through its direct-fit socket technology, Amparo enables clinicians to provide a durable, high-performance prosthetic in under two hours—a process that traditionally takes up to three months and multiple appointments.
Made from re-moldable thermoplastic, Amparo’s sockets adapt to changes in the residual limb, ensuring long-term comfort and significantly reducing replacement costs. This approach enhances adaptability, accelerates rehabilitation, and expands access to high-quality prosthetic care across diverse healthcare settings.
Amparo exemplifies the kind of innovation we seek to solutions that are both scalable and deeply human,” said Rita Branco VC Investment Partner at 3xP Global. “Their technology not only transforms the speed and quality of prosthetic care but also expands access for people in underserved and conflict-affected regions. By investing in Amparo, we’re supporting a company that aligns perfectly with our vision of driving global impact through purposeful, practical innovation”.
With more than 5,000 fittings across 40+ countries and a presence in over 200 clinics worldwide, including those in conflict and low-resource environments, Amparo’s impact is global and growing. Its product portfolio—featuring the Confidence, Resilience, and Pediatric sockets, as well as the upcoming Asha Socket and the Majicast hydrostatic fitting system—delivers scalable, repeatable solutions suited for both advanced healthcare systems and humanitarian missions.
By integrating outcome-measurement tools such as Motio Stepwatch, Amparo also supports data-driven rehabilitation, empowering clinicians with insights that improve patient outcomes and enhance mobility recovery.
“This investment is a pivotal step in Amparo’s journey to scale globally,” said Frederico Carpinteiro, CEO of Amparo. “With a second manufacturing facility in Portugal, expanded distribution, and continued R&D on breakthrough products like Majicast and the Asha Socket, we are building the infrastructure to deliver sustainable growth and global impact. Most importantly, this funding allows us to advance our mission of making prosthetic care faster, more affordable, and accessible to people with limb loss everywhere.”
Amparo’s innovation is powered by engineering excellence and a deep commitment to patient care.
“This investment strengthens our ability to advance socket technology through engineering and innovation,” added Wesley Teerlink, CTO of Amparo. “With Majicast, hydrostatic fitting, and new product lines like the Asha Socket, we’re creating scalable, repeatable solutions that deliver consistent outcomes. Our R&D focus is on improving patient comfort while equipping clinicians with reliable, data-driven tools to transform prosthetic care globally.”
Operating across six continents, Amparo partners with healthcare providers, humanitarian organizations, and distributors to expand access to prosthetic care, restore mobility, and empower amputees to live active, independent lives.
At 3xP Global, we invest in purpose-driven companies that merge innovation, scalability, and measurable social impact. Our partnership with Amparo underscores the commitment of accelerating the path toward a world where prosthetic care is faster, fairer, and accessible to all.
